Tobacco Consumption Concerns With the Use of CYP1A2 Metabolized Antidepressants.
From the Department of Psychiatry and the Department of Molecular Genetics, Pharmacogenetics, and Hormonology, Assistance Publique-Hôpitaux de Paris, and the French Institute of Health and Medical Research, Bicêtre University Hospital, Université Paris-Sud, Le Kremlin Bicêtre, France.
Florence
F
Gressier
From the Department of Psychiatry and the Department of Molecular Genetics, Pharmacogenetics, and Hormonology, Assistance Publique-Hôpitaux de Paris, and the French Institute of Health and Medical Research, Bicêtre University Hospital, Université Paris-Sud, Le Kremlin Bicêtre, France.
Samuel
S
Rotenberg
From the Department of Psychiatry and the Department of Molecular Genetics, Pharmacogenetics, and Hormonology, Assistance Publique-Hôpitaux de Paris, and the French Institute of Health and Medical Research, Bicêtre University Hospital, Université Paris-Sud, Le Kremlin Bicêtre, France.
Abd El Kader
AEK
Ait Tayeb
From the Department of Psychiatry and the Department of Molecular Genetics, Pharmacogenetics, and Hormonology, Assistance Publique-Hôpitaux de Paris, and the French Institute of Health and Medical Research, Bicêtre University Hospital, Université Paris-Sud, Le Kremlin Bicêtre, France.
Romain
R
Colle
From the Department of Psychiatry and the Department of Molecular Genetics, Pharmacogenetics, and Hormonology, Assistance Publique-Hôpitaux de Paris, and the French Institute of Health and Medical Research, Bicêtre University Hospital, Université Paris-Sud, Le Kremlin Bicêtre, France.
Patrick
P
Hardy
From the Department of Psychiatry and the Department of Molecular Genetics, Pharmacogenetics, and Hormonology, Assistance Publique-Hôpitaux de Paris, and the French Institute of Health and Medical Research, Bicêtre University Hospital, Université Paris-Sud, Le Kremlin Bicêtre, France.
Laurent
L
Becquemont
From the Department of Psychiatry and the Department of Molecular Genetics, Pharmacogenetics, and Hormonology, Assistance Publique-Hôpitaux de Paris, and the French Institute of Health and Medical Research, Bicêtre University Hospital, Université Paris-Sud, Le Kremlin Bicêtre, France.
Céline
C
Verstuyft
From the Department of Psychiatry and the Department of Molecular Genetics, Pharmacogenetics, and Hormonology, Assistance Publique-Hôpitaux de Paris, and the French Institute of Health and Medical Research, Bicêtre University Hospital, Université Paris-Sud, Le Kremlin Bicêtre, France.
Emmanuelle
E
Corruble
D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D019388:Cytochrome P-450 CYP1A2 / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005838:Genotype; D006579:Heterozygote; D006801:Humans; D007099:Imipramine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D012008:Recurrence; D014029:Tobacco Use Disorder / Q000150:complications* / Q000235:genetics
D000929:Antidepressive Agents, Tricyclic; D019388:Cytochrome P-450 CYP1A2; D007099:Imipramine